by Sean Hutchinson | Feb 5, 2026 | US & International
In many countries, patents are granted for inventions and last for 20 years, subject to payment of renewal fees at regular intervals. However, some countries permit the patent term to be extended provided certain requirements are met. In the UK and the EU, a...
by Sean Hughes | Jan 28, 2026 | US & International
At its core, the decision reinforces a stringent US approach to patent sufficiency: if a patent specification does not clearly support and enable the full scope of the claims at the priority date, those claims are vulnerable, no matter how valuable the underlying...
by Chloe Sullivan | Jan 20, 2026 | UPC
To briefly recap the key events leading up to this decision, the US Supreme Court found a lack of enablement when assessing the PCSK9 antibody claims in Amgen’s US patent and the Munich Central Division of the UPC initially revoked the European equivalent based on...
by Luke Pettit | Jan 15, 2026 | UPC
Background The UPC Court of Appeal’s decision in Otec v. Steros provides an interesting insight into claim interpretation and the constraints on relying on post-filing experimental evidence at the UPC. The case, UPC Court of Appeal decision 579/2025, arose from a...
by David Eyre | Dec 22, 2025 | EPO
Background Under G 1/92, a product on the market was not considered “available” as prior art under Article 54(2) EPC if the skilled person could not reproduce it without undue burden. This created a peculiar legal fiction: a product could be purchased yet legally...
by Sean Hutchinson | Dec 19, 2025 | Trademarks
Background For a democracy to function, it is essential that every politician standing for office can voice their opinion and that every political party hoping to form the next government can promote their agenda. This cornerstone of democratic society, encompassed by...
Recent Comments